BUSINESS● LOWAug 10 · Aug 10, 2026, 6:54 PM
Oruka Therapeutics GAAP EPS of -$0.55 misses by $0.01
Seeking Alpha Tech
Oruka Therapeutics reported GAAP Earnings Per Share of -$0.55, which missed analyst expectations by $0.01. This is a routine financial report.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS31m agoBlackRock, GIC among investors chasing Indian telecom major Jio's IPO as anchor bids top $26 billionCNBCBUSINESS37m agoSpaceX Q3 earnings: Revenue seen surging to $13B as AI business takes centre stageSeeking Alpha Tech